nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—Teniposide—lung cancer	0.21	0.3	CbGbCtD
Lomefloxacin—TOP2A—Etoposide—lung cancer	0.0928	0.132	CbGbCtD
Lomefloxacin—TOP2A—Doxorubicin—lung cancer	0.0633	0.0903	CbGbCtD
Lomefloxacin—ABCC2—Paclitaxel—lung cancer	0.0482	0.0687	CbGbCtD
Lomefloxacin—ABCC2—Irinotecan—lung cancer	0.0475	0.0678	CbGbCtD
Lomefloxacin—ABCC2—Vinblastine—lung cancer	0.0423	0.0603	CbGbCtD
Lomefloxacin—ABCC2—Cisplatin—lung cancer	0.0388	0.0553	CbGbCtD
Lomefloxacin—ABCC2—Etoposide—lung cancer	0.0381	0.0543	CbGbCtD
Lomefloxacin—ABCC2—Docetaxel—lung cancer	0.0348	0.0497	CbGbCtD
Lomefloxacin—ABCC2—Doxorubicin—lung cancer	0.026	0.037	CbGbCtD
Lomefloxacin—ABCC2—Methotrexate—lung cancer	0.0252	0.0359	CbGbCtD
Lomefloxacin—CYP1A2—Erlotinib—lung cancer	0.0196	0.028	CbGbCtD
Lomefloxacin—CYP1A2—Etoposide—lung cancer	0.0142	0.0202	CbGbCtD
Lomefloxacin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000604	0.097	CbGdCrCtD
Lomefloxacin—TOP2A—Irinotecan—Topotecan—lung cancer	0.000517	0.083	CbGdCrCtD
Lomefloxacin—Gatifloxacin—ALB—lung cancer	0.000512	0.243	CrCbGaD
Lomefloxacin—Norfloxacin—CYP2A6—lung cancer	0.000489	0.232	CrCbGaD
Lomefloxacin—TOP2A—Erlotinib—Gefitinib—lung cancer	0.000451	0.0725	CbGdCrCtD
Lomefloxacin—TOP2A—Topotecan—Irinotecan—lung cancer	0.00043	0.069	CbGdCrCtD
Lomefloxacin—TOP2A—Etoposide—Teniposide—lung cancer	0.000427	0.0686	CbGdCrCtD
Lomefloxacin—TOP2A—Vindesine—Vinorelbine—lung cancer	0.000384	0.0617	CbGdCrCtD
Lomefloxacin—Norfloxacin—CYP1A1—lung cancer	0.000343	0.163	CrCbGaD
Lomefloxacin—TOP2A—Podofilox—Teniposide—lung cancer	0.000326	0.0523	CbGdCrCtD
Lomefloxacin—Sparfloxacin—ABCB1—lung cancer	0.000319	0.152	CrCbGaD
Lomefloxacin—TOP2A—Vindesine—Vinblastine—lung cancer	0.000307	0.0493	CbGdCrCtD
Lomefloxacin—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.000307	0.0492	CbGdCrCtD
Lomefloxacin—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000302	0.0484	CbGdCrCtD
Lomefloxacin—TOP2A—Afatinib—Gefitinib—lung cancer	0.000295	0.0474	CbGdCrCtD
Lomefloxacin—TOP2A—Gefitinib—Erlotinib—lung cancer	0.000289	0.0465	CbGdCrCtD
Lomefloxacin—Levofloxacin—ABCB1—lung cancer	0.000224	0.107	CrCbGaD
Lomefloxacin—Ciprofloxacin—ABCB1—lung cancer	0.000217	0.103	CrCbGaD
Lomefloxacin—TOP2A—Vincristine—Vinorelbine—lung cancer	0.000207	0.0333	CbGdCrCtD
Lomefloxacin—TOP2A—Vinorelbine—Vinblastine—lung cancer	0.000194	0.0311	CbGdCrCtD
Lomefloxacin—TOP2A—Teniposide—Etoposide—lung cancer	0.000194	0.0311	CbGdCrCtD
Lomefloxacin—TOP2A—Podofilox—Etoposide—lung cancer	0.000194	0.0311	CbGdCrCtD
Lomefloxacin—TOP2A—Vinblastine—Vinorelbine—lung cancer	0.000167	0.0268	CbGdCrCtD
Lomefloxacin—TOP2A—Vincristine—Vinblastine—lung cancer	0.000166	0.0266	CbGdCrCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000163	0.002	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—lung cancer	0.000163	0.00199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—lung cancer	0.000163	0.00199	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTA4—lung cancer	0.000161	0.00197	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—lung cancer	0.000161	0.00197	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTA2—lung cancer	0.000157	0.00192	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000156	0.00191	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000156	0.00191	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—AVP—lung cancer	0.000155	0.00189	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000154	0.00188	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000153	0.00188	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTA1—lung cancer	0.000152	0.00185	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—lung cancer	0.000151	0.00184	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TYMS—lung cancer	0.000147	0.0018	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	0.000145	0.00177	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTP1—lung cancer	0.000143	0.00175	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000143	0.00174	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—lung cancer	0.000143	0.00174	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—UGT1A1—lung cancer	0.000141	0.00172	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000141	0.00172	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	0.00014	0.00171	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—lung cancer	0.000137	0.00168	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000133	0.00162	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CAT—lung cancer	0.000132	0.00161	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTM1—lung cancer	0.000132	0.00161	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000131	0.0016	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.00013	0.00159	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CNDP2—lung cancer	0.000128	0.00157	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM2—lung cancer	0.000128	0.00157	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—FOXM1—lung cancer	0.000127	0.00156	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000127	0.00155	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM2—lung cancer	0.000126	0.00154	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	0.000125	0.00153	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—AVP—lung cancer	0.000121	0.00148	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—lung cancer	0.000121	0.00148	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—HPGDS—lung cancer	0.00012	0.00147	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1B—lung cancer	0.000118	0.00144	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	0.000118	0.00144	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—lung cancer	0.000118	0.00144	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—lung cancer	0.000118	0.00144	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000117	0.00143	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTT1—lung cancer	0.000116	0.00142	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—lung cancer	0.000116	0.00142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2A7—lung cancer	0.000116	0.00142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GCLC—lung cancer	0.000115	0.00141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2A7—lung cancer	0.000114	0.0014	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—lung cancer	0.000113	0.00138	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000113	0.00138	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000111	0.00136	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—lung cancer	0.00011	0.00135	CbGpPWpGaD
Lomefloxacin—TOP2A—Cytarabine—Gemcitabine—lung cancer	0.000109	0.0175	CbGdCrCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000108	0.00132	CbGpPWpGaD
Lomefloxacin—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000107	0.000514	CcSEcCtD
Lomefloxacin—Vomiting—Vinorelbine—lung cancer	0.000107	0.000511	CcSEcCtD
Lomefloxacin—Renal failure—Methotrexate—lung cancer	0.000106	0.000509	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—GNG11—lung cancer	0.000106	0.00129	CbGpPWpGaD
Lomefloxacin—Rash—Vinorelbine—lung cancer	0.000106	0.000507	CcSEcCtD
Lomefloxacin—Dermatitis—Vinorelbine—lung cancer	0.000106	0.000507	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—PPP2R1B—lung cancer	0.000106	0.00129	CbGpPWpGaD
Lomefloxacin—Hypotension—Paclitaxel—lung cancer	0.000105	0.000506	CcSEcCtD
Lomefloxacin—Stomatitis—Methotrexate—lung cancer	0.000105	0.000505	CcSEcCtD
Lomefloxacin—Headache—Vinorelbine—lung cancer	0.000105	0.000504	CcSEcCtD
Lomefloxacin—Syncope—Docetaxel—lung cancer	0.000105	0.000504	CcSEcCtD
Lomefloxacin—Conjunctivitis—Methotrexate—lung cancer	0.000105	0.000504	CcSEcCtD
Lomefloxacin—Dysphagia—Doxorubicin—lung cancer	0.000105	0.000503	CcSEcCtD
Lomefloxacin—Leukopenia—Docetaxel—lung cancer	0.000105	0.000503	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000105	0.00128	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000104	0.00128	CbGpPWpGaD
Lomefloxacin—Eosinophilia—Doxorubicin—lung cancer	0.000104	0.000498	CcSEcCtD
Lomefloxacin—Feeling abnormal—Cisplatin—lung cancer	0.000104	0.000496	CcSEcCtD
Lomefloxacin—Paraesthesia—Etoposide—lung cancer	0.000103	0.000495	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTA3—lung cancer	0.000103	0.00126	CbGpPWpGaD
Lomefloxacin—Haematuria—Methotrexate—lung cancer	0.000103	0.000494	CcSEcCtD
Lomefloxacin—Loss of consciousness—Docetaxel—lung cancer	0.000103	0.000494	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000103	0.000493	CcSEcCtD
Lomefloxacin—Dyspnoea—Etoposide—lung cancer	0.000103	0.000492	CcSEcCtD
Lomefloxacin—Somnolence—Etoposide—lung cancer	0.000102	0.000491	CcSEcCtD
Lomefloxacin—Cough—Docetaxel—lung cancer	0.000102	0.00049	CcSEcCtD
Lomefloxacin—Angina pectoris—Doxorubicin—lung cancer	0.000102	0.00049	CcSEcCtD
Lomefloxacin—Insomnia—Paclitaxel—lung cancer	0.000102	0.000489	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—lung cancer	0.000102	0.00125	CbGpPWpGaD
Lomefloxacin—Epistaxis—Methotrexate—lung cancer	0.000102	0.000489	CcSEcCtD
Lomefloxacin—Hypersensitivity—Irinotecan—lung cancer	0.000102	0.000489	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTA3—lung cancer	0.000102	0.00124	CbGpPWpGaD
Lomefloxacin—Convulsion—Docetaxel—lung cancer	0.000102	0.000487	CcSEcCtD
Lomefloxacin—Paraesthesia—Paclitaxel—lung cancer	0.000101	0.000486	CcSEcCtD
Lomefloxacin—Hypertension—Docetaxel—lung cancer	0.000101	0.000485	CcSEcCtD
Lomefloxacin—Agranulocytosis—Methotrexate—lung cancer	0.000101	0.000484	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—LMNA—lung cancer	0.000101	0.00123	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Paclitaxel—lung cancer	0.000101	0.000482	CcSEcCtD
Lomefloxacin—Somnolence—Paclitaxel—lung cancer	0.0001	0.000481	CcSEcCtD
Lomefloxacin—Decreased appetite—Etoposide—lung cancer	0.0001	0.00048	CcSEcCtD
Lomefloxacin—Myalgia—Docetaxel—lung cancer	9.98e-05	0.000478	CcSEcCtD
Lomefloxacin—Arthralgia—Docetaxel—lung cancer	9.98e-05	0.000478	CcSEcCtD
Lomefloxacin—Chest pain—Docetaxel—lung cancer	9.98e-05	0.000478	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	9.97e-05	0.00122	CbGpPWpGaD
Lomefloxacin—Nausea—Vinorelbine—lung cancer	9.97e-05	0.000478	CcSEcCtD
Lomefloxacin—Dyspepsia—Paclitaxel—lung cancer	9.94e-05	0.000476	CcSEcCtD
Lomefloxacin—Asthenia—Irinotecan—lung cancer	9.93e-05	0.000476	CcSEcCtD
Lomefloxacin—Fatigue—Etoposide—lung cancer	9.93e-05	0.000476	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—lung cancer	9.87e-05	0.00121	CbGpPWpGaD
Lomefloxacin—Constipation—Etoposide—lung cancer	9.85e-05	0.000472	CcSEcCtD
Lomefloxacin—Dysuria—Doxorubicin—lung cancer	9.82e-05	0.000471	CcSEcCtD
Lomefloxacin—Decreased appetite—Paclitaxel—lung cancer	9.81e-05	0.00047	CcSEcCtD
Lomefloxacin—Dry mouth—Docetaxel—lung cancer	9.76e-05	0.000468	CcSEcCtD
Lomefloxacin—Fatigue—Paclitaxel—lung cancer	9.73e-05	0.000466	CcSEcCtD
Lomefloxacin—Hepatitis—Methotrexate—lung cancer	9.71e-05	0.000465	CcSEcCtD
Lomefloxacin—Asthenia—Gemcitabine—lung cancer	9.67e-05	0.000464	CcSEcCtD
Lomefloxacin—Constipation—Paclitaxel—lung cancer	9.65e-05	0.000463	CcSEcCtD
Lomefloxacin—Confusional state—Docetaxel—lung cancer	9.65e-05	0.000462	CcSEcCtD
Lomefloxacin—Pharyngitis—Methotrexate—lung cancer	9.63e-05	0.000462	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Doxorubicin—lung cancer	9.58e-05	0.000459	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Docetaxel—lung cancer	9.57e-05	0.000459	CcSEcCtD
Lomefloxacin—Oedema—Docetaxel—lung cancer	9.57e-05	0.000459	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—lung cancer	9.55e-05	0.00117	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	9.55e-05	0.00117	CbGpPWpGaD
Lomefloxacin—Pruritus—Gemcitabine—lung cancer	9.54e-05	0.000457	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG2—lung cancer	9.52e-05	0.00116	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY1—lung cancer	9.52e-05	0.00116	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Etoposide—lung cancer	9.49e-05	0.000455	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Doxorubicin—lung cancer	9.47e-05	0.000454	CcSEcCtD
Lomefloxacin—Diarrhoea—Irinotecan—lung cancer	9.47e-05	0.000454	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTA4—lung cancer	9.44e-05	0.00115	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—lung cancer	9.42e-05	0.00115	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Etoposide—lung cancer	9.41e-05	0.000451	CcSEcCtD
Lomefloxacin—Shock—Docetaxel—lung cancer	9.41e-05	0.000451	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Docetaxel—lung cancer	9.37e-05	0.000449	CcSEcCtD
Lomefloxacin—Visual impairment—Methotrexate—lung cancer	9.35e-05	0.000448	CcSEcCtD
Lomefloxacin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	9.35e-05	0.015	CbGdCrCtD
Lomefloxacin—TOP2A—Epirubicin—Doxorubicin—lung cancer	9.35e-05	0.015	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Doxorubicin—lung cancer	9.35e-05	0.015	CbGdCrCtD
Lomefloxacin—Tachycardia—Docetaxel—lung cancer	9.34e-05	0.000448	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTA4—lung cancer	9.32e-05	0.00114	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Paclitaxel—lung cancer	9.3e-05	0.000446	CcSEcCtD
Lomefloxacin—Skin disorder—Docetaxel—lung cancer	9.29e-05	0.000445	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	9.28e-05	0.000445	CcSEcCtD
Lomefloxacin—Hypersensitivity—Cisplatin—lung cancer	9.26e-05	0.000444	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Paclitaxel—lung cancer	9.23e-05	0.000442	CcSEcCtD
Lomefloxacin—Diarrhoea—Gemcitabine—lung cancer	9.22e-05	0.000442	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTA2—lung cancer	9.2e-05	0.00112	CbGpPWpGaD
Lomefloxacin—Renal failure—Doxorubicin—lung cancer	9.2e-05	0.000441	CcSEcCtD
Lomefloxacin—Erythema multiforme—Methotrexate—lung cancer	9.18e-05	0.00044	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Doxorubicin—lung cancer	9.18e-05	0.00044	CcSEcCtD
Lomefloxacin—Dizziness—Irinotecan—lung cancer	9.15e-05	0.000439	CcSEcCtD
Lomefloxacin—Urticaria—Etoposide—lung cancer	9.15e-05	0.000438	CcSEcCtD
Lomefloxacin—Stomatitis—Doxorubicin—lung cancer	9.13e-05	0.000437	CcSEcCtD
Lomefloxacin—Anorexia—Docetaxel—lung cancer	9.12e-05	0.000437	CcSEcCtD
Lomefloxacin—Abdominal pain—Etoposide—lung cancer	9.1e-05	0.000436	CcSEcCtD
Lomefloxacin—Conjunctivitis—Doxorubicin—lung cancer	9.1e-05	0.000436	CcSEcCtD
Lomefloxacin—Tinnitus—Methotrexate—lung cancer	9.05e-05	0.000434	CcSEcCtD
Lomefloxacin—Asthenia—Cisplatin—lung cancer	9.02e-05	0.000432	CcSEcCtD
Lomefloxacin—Urticaria—Paclitaxel—lung cancer	8.97e-05	0.00043	CcSEcCtD
Lomefloxacin—Hypotension—Docetaxel—lung cancer	8.94e-05	0.000429	CcSEcCtD
Lomefloxacin—Haematuria—Doxorubicin—lung cancer	8.93e-05	0.000428	CcSEcCtD
Lomefloxacin—Abdominal pain—Paclitaxel—lung cancer	8.92e-05	0.000428	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTA1—lung cancer	8.88e-05	0.00109	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	8.87e-05	0.00108	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TF—lung cancer	8.85e-05	0.00108	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	8.84e-05	0.00108	CbGpPWpGaD
Lomefloxacin—Epistaxis—Doxorubicin—lung cancer	8.83e-05	0.000423	CcSEcCtD
Lomefloxacin—Vomiting—Irinotecan—lung cancer	8.8e-05	0.000422	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	8.75e-05	0.00107	CbGpPWpGaD
Lomefloxacin—Agranulocytosis—Doxorubicin—lung cancer	8.74e-05	0.000419	CcSEcCtD
Lomefloxacin—Rash—Irinotecan—lung cancer	8.73e-05	0.000418	CcSEcCtD
Lomefloxacin—Dermatitis—Irinotecan—lung cancer	8.72e-05	0.000418	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Docetaxel—lung cancer	8.72e-05	0.000418	CcSEcCtD
Lomefloxacin—Chills—Methotrexate—lung cancer	8.71e-05	0.000417	CcSEcCtD
Lomefloxacin—Headache—Irinotecan—lung cancer	8.67e-05	0.000416	CcSEcCtD
Lomefloxacin—Insomnia—Docetaxel—lung cancer	8.65e-05	0.000415	CcSEcCtD
Lomefloxacin—Diarrhoea—Cisplatin—lung cancer	8.6e-05	0.000412	CcSEcCtD
Lomefloxacin—Paraesthesia—Docetaxel—lung cancer	8.59e-05	0.000412	CcSEcCtD
Lomefloxacin—Vomiting—Gemcitabine—lung cancer	8.57e-05	0.000411	CcSEcCtD
Lomefloxacin—Bradycardia—Doxorubicin—lung cancer	8.56e-05	0.00041	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	8.55e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—lung cancer	8.54e-05	0.00104	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCC3—lung cancer	8.54e-05	0.00104	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Docetaxel—lung cancer	8.53e-05	0.000409	CcSEcCtD
Lomefloxacin—Somnolence—Docetaxel—lung cancer	8.51e-05	0.000408	CcSEcCtD
Lomefloxacin—Rash—Gemcitabine—lung cancer	8.5e-05	0.000407	CcSEcCtD
Lomefloxacin—Dermatitis—Gemcitabine—lung cancer	8.49e-05	0.000407	CcSEcCtD
Lomefloxacin—Hypersensitivity—Etoposide—lung cancer	8.48e-05	0.000407	CcSEcCtD
Lomefloxacin—Headache—Gemcitabine—lung cancer	8.45e-05	0.000405	CcSEcCtD
Lomefloxacin—Rhinitis—Doxorubicin—lung cancer	8.43e-05	0.000404	CcSEcCtD
Lomefloxacin—Dyspepsia—Docetaxel—lung cancer	8.42e-05	0.000404	CcSEcCtD
Lomefloxacin—Hepatitis—Doxorubicin—lung cancer	8.4e-05	0.000403	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—AKR1C1—lung cancer	8.39e-05	0.00102	CbGpPWpGaD
Lomefloxacin—Pharyngitis—Doxorubicin—lung cancer	8.34e-05	0.0004	CcSEcCtD
Lomefloxacin—Decreased appetite—Docetaxel—lung cancer	8.32e-05	0.000399	CcSEcCtD
Lomefloxacin—Hypersensitivity—Paclitaxel—lung cancer	8.32e-05	0.000399	CcSEcCtD
Lomefloxacin—Dysgeusia—Methotrexate—lung cancer	8.27e-05	0.000397	CcSEcCtD
Lomefloxacin—Asthenia—Etoposide—lung cancer	8.26e-05	0.000396	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—UGT1A1—lung cancer	8.26e-05	0.00101	CbGpPWpGaD
Lomefloxacin—Fatigue—Docetaxel—lung cancer	8.25e-05	0.000395	CcSEcCtD
Lomefloxacin—Nausea—Irinotecan—lung cancer	8.22e-05	0.000394	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—lung cancer	8.18e-05	0.001	CbGpPWpGaD
Lomefloxacin—Constipation—Docetaxel—lung cancer	8.18e-05	0.000392	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—lung cancer	8.18e-05	0.001	CbGpPWpGaD
Lomefloxacin—Back pain—Methotrexate—lung cancer	8.17e-05	0.000392	CcSEcCtD
Lomefloxacin—Pruritus—Etoposide—lung cancer	8.15e-05	0.00039	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—UGT1A1—lung cancer	8.14e-05	0.000995	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	8.12e-05	0.000992	CbGpPWpGaD
Lomefloxacin—Visual impairment—Doxorubicin—lung cancer	8.1e-05	0.000388	CcSEcCtD
Lomefloxacin—Asthenia—Paclitaxel—lung cancer	8.1e-05	0.000388	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTP1—lung cancer	8.07e-05	0.000986	CbGpPWpGaD
Lomefloxacin—Nausea—Gemcitabine—lung cancer	8.01e-05	0.000384	CcSEcCtD
Lomefloxacin—Vomiting—Cisplatin—lung cancer	7.99e-05	0.000383	CcSEcCtD
Lomefloxacin—Pruritus—Paclitaxel—lung cancer	7.99e-05	0.000383	CcSEcCtD
Lomefloxacin—Erythema multiforme—Doxorubicin—lung cancer	7.95e-05	0.000381	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	7.94e-05	0.00097	CbGpPWpGaD
Lomefloxacin—Rash—Cisplatin—lung cancer	7.92e-05	0.00038	CcSEcCtD
Lomefloxacin—Dermatitis—Cisplatin—lung cancer	7.92e-05	0.000379	CcSEcCtD
Lomefloxacin—Feeling abnormal—Docetaxel—lung cancer	7.88e-05	0.000378	CcSEcCtD
Lomefloxacin—Diarrhoea—Etoposide—lung cancer	7.88e-05	0.000378	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Methotrexate—lung cancer	7.84e-05	0.000376	CcSEcCtD
Lomefloxacin—Tinnitus—Doxorubicin—lung cancer	7.84e-05	0.000376	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Docetaxel—lung cancer	7.82e-05	0.000375	CcSEcCtD
Lomefloxacin—TOP2A—Azacitidine—Gemcitabine—lung cancer	7.81e-05	0.0125	CbGdCrCtD
Lomefloxacin—Anaemia—Methotrexate—lung cancer	7.81e-05	0.000374	CcSEcCtD
Lomefloxacin—Flushing—Doxorubicin—lung cancer	7.8e-05	0.000374	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—GNG11—lung cancer	7.74e-05	0.000946	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	7.74e-05	0.000946	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	7.73e-05	0.000944	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Paclitaxel—lung cancer	7.72e-05	0.00037	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	7.71e-05	0.000942	CbGpPWpGaD
Lomefloxacin—Malaise—Methotrexate—lung cancer	7.62e-05	0.000365	CcSEcCtD
Lomefloxacin—Dizziness—Etoposide—lung cancer	7.61e-05	0.000365	CcSEcCtD
Lomefloxacin—Vertigo—Methotrexate—lung cancer	7.59e-05	0.000364	CcSEcCtD
Lomefloxacin—Abdominal pain—Docetaxel—lung cancer	7.56e-05	0.000363	CcSEcCtD
Lomefloxacin—Leukopenia—Methotrexate—lung cancer	7.56e-05	0.000363	CcSEcCtD
Lomefloxacin—Chills—Doxorubicin—lung cancer	7.54e-05	0.000361	CcSEcCtD
Lomefloxacin—Arrhythmia—Doxorubicin—lung cancer	7.51e-05	0.00036	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	7.48e-05	0.000914	CbGpPWpGaD
Lomefloxacin—Dizziness—Paclitaxel—lung cancer	7.46e-05	0.000358	CcSEcCtD
Lomefloxacin—Nausea—Cisplatin—lung cancer	7.46e-05	0.000358	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	7.46e-05	0.000911	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—lung cancer	7.43e-05	0.000908	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—lung cancer	7.41e-05	0.000906	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUN—lung cancer	7.4e-05	0.000905	CbGpPWpGaD
Lomefloxacin—Cough—Methotrexate—lung cancer	7.37e-05	0.000353	CcSEcCtD
Lomefloxacin—Convulsion—Methotrexate—lung cancer	7.32e-05	0.000351	CcSEcCtD
Lomefloxacin—Vomiting—Etoposide—lung cancer	7.32e-05	0.000351	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—lung cancer	7.32e-05	0.000894	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—MDM2—lung cancer	7.28e-05	0.00089	CbGpPWpGaD
Lomefloxacin—Rash—Etoposide—lung cancer	7.26e-05	0.000348	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	7.26e-05	0.000887	CbGpPWpGaD
Lomefloxacin—Dermatitis—Etoposide—lung cancer	7.25e-05	0.000348	CcSEcCtD
Lomefloxacin—Headache—Etoposide—lung cancer	7.21e-05	0.000346	CcSEcCtD
Lomefloxacin—Flatulence—Doxorubicin—lung cancer	7.21e-05	0.000346	CcSEcCtD
Lomefloxacin—Chest pain—Methotrexate—lung cancer	7.19e-05	0.000345	CcSEcCtD
Lomefloxacin—Myalgia—Methotrexate—lung cancer	7.19e-05	0.000345	CcSEcCtD
Lomefloxacin—Arthralgia—Methotrexate—lung cancer	7.19e-05	0.000345	CcSEcCtD
Lomefloxacin—Tension—Doxorubicin—lung cancer	7.18e-05	0.000344	CcSEcCtD
Lomefloxacin—Vomiting—Paclitaxel—lung cancer	7.18e-05	0.000344	CcSEcCtD
Lomefloxacin—Dysgeusia—Doxorubicin—lung cancer	7.16e-05	0.000343	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—PTEN—lung cancer	7.16e-05	0.000875	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.12e-05	0.00087	CbGpPWpGaD
Lomefloxacin—Rash—Paclitaxel—lung cancer	7.12e-05	0.000341	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	7.11e-05	0.000869	CbGpPWpGaD
Lomefloxacin—Dermatitis—Paclitaxel—lung cancer	7.11e-05	0.000341	CcSEcCtD
Lomefloxacin—Discomfort—Methotrexate—lung cancer	7.11e-05	0.000341	CcSEcCtD
Lomefloxacin—Nervousness—Doxorubicin—lung cancer	7.11e-05	0.000341	CcSEcCtD
Lomefloxacin—Back pain—Doxorubicin—lung cancer	7.08e-05	0.000339	CcSEcCtD
Lomefloxacin—Headache—Paclitaxel—lung cancer	7.07e-05	0.000339	CcSEcCtD
Lomefloxacin—Hypersensitivity—Docetaxel—lung cancer	7.05e-05	0.000338	CcSEcCtD
Lomefloxacin—Muscle spasms—Doxorubicin—lung cancer	7.03e-05	0.000337	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	7.02e-05	0.000858	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—HPGDS—lung cancer	7.02e-05	0.000858	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ADCY1—lung cancer	6.96e-05	0.000851	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—lung cancer	6.96e-05	0.000851	CbGpPWpGaD
Lomefloxacin—Confusional state—Methotrexate—lung cancer	6.95e-05	0.000333	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6.92e-05	0.000845	CbGpPWpGaD
Lomefloxacin—Anaphylactic shock—Methotrexate—lung cancer	6.9e-05	0.000331	CcSEcCtD
Lomefloxacin—Asthenia—Docetaxel—lung cancer	6.86e-05	0.000329	CcSEcCtD
Lomefloxacin—Nausea—Etoposide—lung cancer	6.84e-05	0.000328	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—EP300—lung cancer	6.83e-05	0.000834	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—lung cancer	6.81e-05	0.000832	CbGpPWpGaD
Lomefloxacin—Ill-defined disorder—Doxorubicin—lung cancer	6.79e-05	0.000325	CcSEcCtD
Lomefloxacin—Pruritus—Docetaxel—lung cancer	6.77e-05	0.000324	CcSEcCtD
Lomefloxacin—Anaemia—Doxorubicin—lung cancer	6.76e-05	0.000324	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Methotrexate—lung cancer	6.75e-05	0.000324	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.74e-05	0.000823	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GCLC—lung cancer	6.73e-05	0.000822	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2A6—lung cancer	6.73e-05	0.000822	CbGpPWpGaD
Lomefloxacin—Agitation—Doxorubicin—lung cancer	6.72e-05	0.000322	CcSEcCtD
Lomefloxacin—Nausea—Paclitaxel—lung cancer	6.71e-05	0.000321	CcSEcCtD
Lomefloxacin—Skin disorder—Methotrexate—lung cancer	6.7e-05	0.000321	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—lung cancer	6.68e-05	0.000816	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Methotrexate—lung cancer	6.67e-05	0.00032	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—TYMS—lung cancer	6.64e-05	0.000812	CbGpPWpGaD
Lomefloxacin—Malaise—Doxorubicin—lung cancer	6.6e-05	0.000316	CcSEcCtD
Lomefloxacin—Vertigo—Doxorubicin—lung cancer	6.57e-05	0.000315	CcSEcCtD
Lomefloxacin—Anorexia—Methotrexate—lung cancer	6.57e-05	0.000315	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	6.57e-05	0.000803	CbGpPWpGaD
Lomefloxacin—Syncope—Doxorubicin—lung cancer	6.56e-05	0.000314	CcSEcCtD
Lomefloxacin—Leukopenia—Doxorubicin—lung cancer	6.55e-05	0.000314	CcSEcCtD
Lomefloxacin—Diarrhoea—Docetaxel—lung cancer	6.55e-05	0.000314	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	6.51e-05	0.000795	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TF—lung cancer	6.47e-05	0.000791	CbGpPWpGaD
Lomefloxacin—Hypotension—Methotrexate—lung cancer	6.44e-05	0.000309	CcSEcCtD
Lomefloxacin—Loss of consciousness—Doxorubicin—lung cancer	6.43e-05	0.000308	CcSEcCtD
Lomefloxacin—Cough—Doxorubicin—lung cancer	6.38e-05	0.000306	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.37e-05	0.000779	CbGpPWpGaD
Lomefloxacin—Convulsion—Doxorubicin—lung cancer	6.34e-05	0.000304	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	6.33e-05	0.000774	CbGpPWpGaD
Lomefloxacin—Dizziness—Docetaxel—lung cancer	6.33e-05	0.000303	CcSEcCtD
Lomefloxacin—Hypertension—Doxorubicin—lung cancer	6.32e-05	0.000303	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Methotrexate—lung cancer	6.28e-05	0.000301	CcSEcCtD
Lomefloxacin—Insomnia—Methotrexate—lung cancer	6.24e-05	0.000299	CcSEcCtD
Lomefloxacin—Arthralgia—Doxorubicin—lung cancer	6.23e-05	0.000299	CcSEcCtD
Lomefloxacin—Chest pain—Doxorubicin—lung cancer	6.23e-05	0.000299	CcSEcCtD
Lomefloxacin—Myalgia—Doxorubicin—lung cancer	6.23e-05	0.000299	CcSEcCtD
Lomefloxacin—Anxiety—Doxorubicin—lung cancer	6.21e-05	0.000298	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.2e-05	0.000757	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Methotrexate—lung cancer	6.19e-05	0.000297	CcSEcCtD
Lomefloxacin—Discomfort—Doxorubicin—lung cancer	6.15e-05	0.000295	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	6.15e-05	0.000752	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Methotrexate—lung cancer	6.15e-05	0.000295	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	6.14e-05	0.00075	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—AVP—lung cancer	6.14e-05	0.00075	CbGpPWpGaD
Lomefloxacin—Somnolence—Methotrexate—lung cancer	6.13e-05	0.000294	CcSEcCtD
Lomefloxacin—Dry mouth—Doxorubicin—lung cancer	6.09e-05	0.000292	CcSEcCtD
Lomefloxacin—Vomiting—Docetaxel—lung cancer	6.08e-05	0.000292	CcSEcCtD
Lomefloxacin—Dyspepsia—Methotrexate—lung cancer	6.07e-05	0.000291	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	6.06e-05	0.000741	CbGpPWpGaD
Lomefloxacin—Rash—Docetaxel—lung cancer	6.03e-05	0.000289	CcSEcCtD
Lomefloxacin—Dermatitis—Docetaxel—lung cancer	6.03e-05	0.000289	CcSEcCtD
Lomefloxacin—Confusional state—Doxorubicin—lung cancer	6.02e-05	0.000289	CcSEcCtD
Lomefloxacin—Decreased appetite—Methotrexate—lung cancer	5.99e-05	0.000287	CcSEcCtD
Lomefloxacin—Headache—Docetaxel—lung cancer	5.99e-05	0.000287	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—lung cancer	5.97e-05	0.00073	CbGpPWpGaD
Lomefloxacin—Anaphylactic shock—Doxorubicin—lung cancer	5.97e-05	0.000286	CcSEcCtD
Lomefloxacin—Oedema—Doxorubicin—lung cancer	5.97e-05	0.000286	CcSEcCtD
Lomefloxacin—Fatigue—Methotrexate—lung cancer	5.95e-05	0.000285	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—lung cancer	5.94e-05	0.000726	CbGpPWpGaD
Lomefloxacin—Shock—Doxorubicin—lung cancer	5.87e-05	0.000282	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Doxorubicin—lung cancer	5.85e-05	0.00028	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	5.84e-05	0.000714	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	5.84e-05	0.000714	CbGpPWpGaD
Lomefloxacin—Tachycardia—Doxorubicin—lung cancer	5.83e-05	0.000279	CcSEcCtD
Lomefloxacin—Skin disorder—Doxorubicin—lung cancer	5.8e-05	0.000278	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—TERT—lung cancer	5.79e-05	0.000707	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Doxorubicin—lung cancer	5.77e-05	0.000277	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.77e-05	0.000705	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.73e-05	0.0007	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2E1—lung cancer	5.72e-05	0.000699	CbGpPWpGaD
Lomefloxacin—Anorexia—Doxorubicin—lung cancer	5.69e-05	0.000273	CcSEcCtD
Lomefloxacin—Nausea—Docetaxel—lung cancer	5.68e-05	0.000272	CcSEcCtD
Lomefloxacin—Feeling abnormal—Methotrexate—lung cancer	5.68e-05	0.000272	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	5.68e-05	0.000694	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	5.68e-05	0.000694	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	5.64e-05	0.00069	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Methotrexate—lung cancer	5.64e-05	0.00027	CcSEcCtD
Lomefloxacin—Hypotension—Doxorubicin—lung cancer	5.58e-05	0.000267	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	5.53e-05	0.000676	CbGpPWpGaD
Lomefloxacin—Urticaria—Methotrexate—lung cancer	5.48e-05	0.000263	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	5.46e-05	0.000668	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Methotrexate—lung cancer	5.45e-05	0.000261	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.44e-05	0.000261	CcSEcCtD
Lomefloxacin—Insomnia—Doxorubicin—lung cancer	5.4e-05	0.000259	CcSEcCtD
Lomefloxacin—Paraesthesia—Doxorubicin—lung cancer	5.36e-05	0.000257	CcSEcCtD
Lomefloxacin—Dyspnoea—Doxorubicin—lung cancer	5.32e-05	0.000255	CcSEcCtD
Lomefloxacin—Somnolence—Doxorubicin—lung cancer	5.31e-05	0.000254	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.26e-05	0.000643	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Doxorubicin—lung cancer	5.26e-05	0.000252	CcSEcCtD
Lomefloxacin—Decreased appetite—Doxorubicin—lung cancer	5.19e-05	0.000249	CcSEcCtD
Lomefloxacin—Fatigue—Doxorubicin—lung cancer	5.15e-05	0.000247	CcSEcCtD
Lomefloxacin—Constipation—Doxorubicin—lung cancer	5.11e-05	0.000245	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.09e-05	0.000622	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	5.09e-05	0.000622	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Methotrexate—lung cancer	5.08e-05	0.000244	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	5.04e-05	0.000616	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	4.98e-05	0.000608	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	4.98e-05	0.000608	CbGpPWpGaD
Lomefloxacin—Asthenia—Methotrexate—lung cancer	4.95e-05	0.000237	CcSEcCtD
Lomefloxacin—Feeling abnormal—Doxorubicin—lung cancer	4.92e-05	0.000236	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—lung cancer	4.89e-05	0.000597	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Doxorubicin—lung cancer	4.88e-05	0.000234	CcSEcCtD
Lomefloxacin—Pruritus—Methotrexate—lung cancer	4.88e-05	0.000234	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	4.79e-05	0.000585	CbGpPWpGaD
Lomefloxacin—Urticaria—Doxorubicin—lung cancer	4.74e-05	0.000227	CcSEcCtD
Lomefloxacin—Abdominal pain—Doxorubicin—lung cancer	4.72e-05	0.000226	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—lung cancer	4.72e-05	0.000577	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Methotrexate—lung cancer	4.72e-05	0.000226	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	4.7e-05	0.000575	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—lung cancer	4.69e-05	0.000573	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	4.65e-05	0.000569	CbGpPWpGaD
Lomefloxacin—Dizziness—Methotrexate—lung cancer	4.56e-05	0.000219	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—RB1—lung cancer	4.5e-05	0.00055	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—AVP—lung cancer	4.49e-05	0.000548	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—lung cancer	4.47e-05	0.000547	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	4.43e-05	0.000541	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Doxorubicin—lung cancer	4.4e-05	0.000211	CcSEcCtD
Lomefloxacin—Vomiting—Methotrexate—lung cancer	4.38e-05	0.00021	CcSEcCtD
Lomefloxacin—Rash—Methotrexate—lung cancer	4.35e-05	0.000208	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—lung cancer	4.35e-05	0.000531	CbGpPWpGaD
Lomefloxacin—Dermatitis—Methotrexate—lung cancer	4.34e-05	0.000208	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—lung cancer	4.34e-05	0.00053	CbGpPWpGaD
Lomefloxacin—Headache—Methotrexate—lung cancer	4.32e-05	0.000207	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.3e-05	0.000525	CbGpPWpGaD
Lomefloxacin—Asthenia—Doxorubicin—lung cancer	4.28e-05	0.000205	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	4.28e-05	0.000523	CbGpPWpGaD
Lomefloxacin—Pruritus—Doxorubicin—lung cancer	4.22e-05	0.000202	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1A1—lung cancer	4.11e-05	0.000502	CbGpPWpGaD
Lomefloxacin—Nausea—Methotrexate—lung cancer	4.1e-05	0.000196	CcSEcCtD
Lomefloxacin—Diarrhoea—Doxorubicin—lung cancer	4.09e-05	0.000196	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	4.05e-05	0.000495	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	4e-05	0.000488	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—lung cancer	3.97e-05	0.000485	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—lung cancer	3.96e-05	0.000484	CbGpPWpGaD
Lomefloxacin—Dizziness—Doxorubicin—lung cancer	3.95e-05	0.000189	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—MDM2—lung cancer	3.84e-05	0.000469	CbGpPWpGaD
Lomefloxacin—Vomiting—Doxorubicin—lung cancer	3.8e-05	0.000182	CcSEcCtD
Lomefloxacin—Rash—Doxorubicin—lung cancer	3.76e-05	0.00018	CcSEcCtD
Lomefloxacin—Dermatitis—Doxorubicin—lung cancer	3.76e-05	0.00018	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	3.74e-05	0.000457	CbGpPWpGaD
Lomefloxacin—Headache—Doxorubicin—lung cancer	3.74e-05	0.000179	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—lung cancer	3.72e-05	0.000454	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	3.62e-05	0.000442	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AZIN2—lung cancer	3.62e-05	0.000442	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—COL4A3BP—lung cancer	3.62e-05	0.000442	CbGpPWpGaD
Lomefloxacin—Nausea—Doxorubicin—lung cancer	3.55e-05	0.00017	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	3.44e-05	0.000421	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—lung cancer	3.43e-05	0.000419	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	3.37e-05	0.000412	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—lung cancer	3.36e-05	0.000411	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—lung cancer	3.35e-05	0.000409	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.27e-05	0.000399	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1A—lung cancer	3.24e-05	0.000395	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	3.09e-05	0.000377	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—EP300—lung cancer	3.08e-05	0.000376	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ATP5H—lung cancer	3.07e-05	0.000376	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—POMC—lung cancer	3.07e-05	0.000375	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	3e-05	0.000367	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.9e-05	0.000355	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.83e-05	0.000345	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—lung cancer	2.76e-05	0.000337	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLBD1—lung cancer	2.74e-05	0.000335	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—lung cancer	2.72e-05	0.000332	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.7e-05	0.000329	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—lung cancer	2.68e-05	0.000328	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSD17B10—lung cancer	2.51e-05	0.000306	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	2.46e-05	0.0003	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CKB—lung cancer	2.33e-05	0.000285	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—lung cancer	2.2e-05	0.000269	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CNDP2—lung cancer	2.19e-05	0.000268	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM2—lung cancer	2.19e-05	0.000268	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTMR3—lung cancer	2.13e-05	0.00026	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PGAM1—lung cancer	2.08e-05	0.000254	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2A7—lung cancer	1.98e-05	0.000242	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SDC4—lung cancer	1.94e-05	0.000237	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—RRM1—lung cancer	1.77e-05	0.000216	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA3—lung cancer	1.77e-05	0.000216	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—B4GALT5—lung cancer	1.66e-05	0.000203	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA4—lung cancer	1.62e-05	0.000197	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.58e-05	0.000193	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA2—lung cancer	1.57e-05	0.000192	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTA1—lung cancer	1.52e-05	0.000186	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCC3—lung cancer	1.5e-05	0.000183	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKR1C1—lung cancer	1.45e-05	0.000178	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UGT1A1—lung cancer	1.41e-05	0.000173	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GNG11—lung cancer	1.36e-05	0.000166	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.35e-05	0.000166	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALDOA—lung cancer	1.3e-05	0.000158	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOA3—lung cancer	1.26e-05	0.000154	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.24e-05	0.000151	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG2—lung cancer	1.22e-05	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADCY1—lung cancer	1.22e-05	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HPGDS—lung cancer	1.2e-05	0.000147	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENO2—lung cancer	1.2e-05	0.000147	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.19e-05	0.000146	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.18e-05	0.000144	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—lung cancer	1.16e-05	0.000142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2A6—lung cancer	1.15e-05	0.000141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GCLC—lung cancer	1.15e-05	0.000141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.15e-05	0.00014	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENO1—lung cancer	1.09e-05	0.000133	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.09e-05	0.000133	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.07e-05	0.000131	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2E1—lung cancer	9.79e-06	0.00012	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NQO1—lung cancer	9.68e-06	0.000118	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.47e-06	0.000116	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.39e-06	0.000115	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—STK11—lung cancer	8.72e-06	0.000107	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.19e-06	0.0001	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—lung cancer	8.07e-06	9.86e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAT—lung cancer	7.85e-06	9.6e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.81e-06	9.54e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCB1—lung cancer	7.64e-06	9.34e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TYMS—lung cancer	7.5e-06	9.17e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—lung cancer	7.42e-06	9.06e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1A1—lung cancer	7.03e-06	8.59e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ERCC2—lung cancer	6.97e-06	8.52e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA1—lung cancer	6.03e-06	7.37e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.78e-06	7.06e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—lung cancer	5.51e-06	6.73e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—POMC—lung cancer	5.24e-06	6.41e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CREBBP—lung cancer	5.11e-06	6.24e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CD—lung cancer	4.84e-06	5.92e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—lung cancer	4.78e-06	5.84e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CB—lung cancer	4.22e-06	5.16e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—lung cancer	4.18e-06	5.11e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTEN—lung cancer	3.65e-06	4.46e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—EP300—lung cancer	3.48e-06	4.25e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—lung cancer	2.57e-06	3.14e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—lung cancer	2.1e-06	2.57e-05	CbGpPWpGaD
